Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Acushnet Holdings, Equity Residential and Fiserv, on Monday. HIGHLIGHTS
Q1 2020 Amphastar Pharmaceuticals Inc Earnings Call
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of...
Q1 2020 Amphastar Pharmaceuticals Inc Earnings Call
All statements on this conference call that are not historical are forward-looking statements, including, among other things, statements relating to the company's expectations regarding future financi
RANCHO CUCAMONGA, Calif., May 07, 2020 -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended March.
Amphastar (AMPH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Amphastar Pharmaceuticals, Inc. (AMPH) announced that the Company will release results for its first quarter of 2020 ended March 31, 2020, after the market closes on Thursday, May 7th, 2020, and will
Needham analyst Serge Belanger assigned a Buy rating to Collegium Pharmaceutical (COLL) today and set a price target of $38.00. The company's shares
Needham analyst Serge Belanger assigned a Buy rating to Collegium Pharmaceutical (COLL – Research Report) today and set a price
Northland Securities analyst Tim Chiang maintained a Buy rating on Amphastar Pharmaceuticals (AMPH) today and set a price target of $23.00. The company's
Northland Securities analyst Tim Chiang maintained a Buy rating on Amphastar Pharmaceuticals ( AMPH – Research Report ) today and set a price target of $23.00 . The company’s shares closed last Th
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE